
Global Health Security Index
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Infectious disease outbreaks—including COVID-19, the Zika virus in the Americas, the Ebola outbreak in West Africa, MERS-CoV in the Middle East, and pandemic influenza—have exposed weaknesses in preventing, detecting, and responding to biological threats. Without adequate measures to address public health emergencies, outbreaks can rapidly spread, costing thousands of lives and billions in economic loss. Ultimately, this threatens global peace and security.
NTI works to build accountability among governments, industry, and international organizations through projects designed to expose health and security gaps, offer innovative and practical solutions, and embed follow-up assessments to check progress.
NTI | bio’s projects address the range of global health security needs, from norms-building around advances in biotechnologies to benchmarking of public health security capabilities in 195 countries.
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Reducing biological risk and enhancing global security
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.